Ani Pharmaceuticals (ANIP) Cash from Investing Activities Growth (5y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.60% |
| Mar 31, 2026 | -72.71% |
| Dec 31, 2025 | 7.92% |
| Sep 30, 2025 | -1.19% |
| Jun 30, 2025 | -19.39% |
| Mar 31, 2025 | 19.18% |
| Dec 31, 2024 | -50.70% |
| Sep 30, 2024 | -190.33% |
| Jun 30, 2024 | -2.37% |
| Mar 31, 2024 | 19.53% |
| Dec 31, 2023 | -63.66% |
| Sep 30, 2023 | 24.40% |
| Jun 30, 2023 | -1.76% |
| Mar 31, 2023 | -0.65% |
| Dec 31, 2022 | 42.53% |
| Sep 30, 2022 | -31.67% |
| Jun 30, 2022 | 23.49% |
| Mar 31, 2022 | 47.20% |
| Dec 31, 2021 | -126.18% |
| Sep 30, 2021 | 11.75% |